The South African government has committed R753 million in emergency funding to keep vital HIV and TB programmes running – and that’s a big deal for the Eastern Cape and Nelson Mandela Bay, where the public health system remains stretched and under pressure.
This comes after the United States cut major health grants, including the PEPFAR programme, which previously injected R7.9 billion annually into HIV/AIDS services in South Africa.
Health Minister Dr Aaron Motsoaledi made the announcement during his department’s Budget Vote in Parliament this week, saying R590 million of the newly allocated funds will be sent directly to provinces through the HIV/AIDS component of the District Health Programme Grant — a lifeline for clinics, outreach workers, and community programmes.
Why It Matters in Nelson Mandela Bay
NMB has some of the highest reported rates of HIV and TB in the province, with many residents relying on public sector services for antiretrovirals, chronic medication collection, and TB treatment. The provincial health system — already under strain — could not afford to absorb the impact of a full PEPFAR withdrawal without support.
“A funding gap of this scale would’ve led to fewer resources, staff burnout, medication delays, and a backslide in care,” says one local clinic nurse, speaking anonymously. “This intervention is critical.”
In addition to the provincial funding:
- R32.1 million will go to the National Department of Health to support programmes like CCMDD (Central Chronic Medicine Dispensing and Distribution), which many patients in the Bay use to collect meds without long clinic queues.
- R132 million will be transferred to the South African Medical Research Council (SAMRC) to drive homegrown HIV and TB research, and possibly boost Eastern Cape academic partnerships and health innovation.
Global Players Step In — But Want Skin in the Game
The Bill and Melinda Gates Foundation and the Wellcome Trust have pledged R100 million each ,but with a condition: for every R100 million, the government must contribute R200 million. The Treasury has agreed, unlocking R600 million for researchers nationally.
These funds will go to support research and innovation, particularly in light of new prevention options like lenacapavir, a long-acting HIV prevention injection administered twice a year, referred to by Minister Motsoaledi as a “game changer” for the country.
South Africa aims to be among the first African countries to roll out lenacapavir by the end of 2025, starting with young women and high-risk communities.
Looking Ahead
For communities like NMB, where women and girls continue to carry the highest burden of HIV, this plan could mean more than just policy; it could mean real, lasting protection for the next generation.
“We’re determined more than ever before to end the scourge of HIV/AIDS as a public health threat,” the Minister said. “We plan to offer lenacapavir to everyone at risk to stay HIV-free.”
While the road ahead will require local coordination, health worker support, and public buy-in, this move, by both government and global partners, signals a renewed commitment to prevention and care.
Leave a Reply